Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
Zhiliang Hu, Bilin Tao, Zhongqi Li, Yan Song, Changhua Yi, Junwei Li, Meng Zhu, Yongxiang Yi, Peng Huang, Jianming Wang
doi: https://doi.org/10.1101/2021.09.02.21263010
Zhiliang Hu
1Nanjing Public Health Medical Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003 China
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
Bilin Tao
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
Zhongqi Li
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
Yan Song
1Nanjing Public Health Medical Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003 China
Changhua Yi
1Nanjing Public Health Medical Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003 China
Junwei Li
1Nanjing Public Health Medical Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003 China
Meng Zhu
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
Yongxiang Yi
1Nanjing Public Health Medical Center, the Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003 China
Peng Huang
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
Jianming Wang
2Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, 211166 China
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Some or all data, models, or code that support the findings of this study are available from the corresponding author upon reasonable request.
Posted September 05, 2021.
Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
Zhiliang Hu, Bilin Tao, Zhongqi Li, Yan Song, Changhua Yi, Junwei Li, Meng Zhu, Yongxiang Yi, Peng Huang, Jianming Wang
medRxiv 2021.09.02.21263010; doi: https://doi.org/10.1101/2021.09.02.21263010
Effectiveness of inactive COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China
Zhiliang Hu, Bilin Tao, Zhongqi Li, Yan Song, Changhua Yi, Junwei Li, Meng Zhu, Yongxiang Yi, Peng Huang, Jianming Wang
medRxiv 2021.09.02.21263010; doi: https://doi.org/10.1101/2021.09.02.21263010
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2628)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12179)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4068)
- Geriatric Medicine (387)
- Health Economics (677)
- Health Informatics (2626)
- Health Policy (998)
- Hematology (361)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3835)
- Nursing (209)
- Nutrition (570)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1108)
- Primary Care Research (448)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)